Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...
One name particularly appealing in the healthcare space is ICON Public Limited Company, a CRO (Contract Research Organization) that has delivered sustained revenue growth. While the macroeconomic ...
Earnings Call Insights: ICON Public Limited Company (NASDAQ:ICLR) Q4 2024 CEO Steve Cutler introduced Barry Balfe as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback